Top PDF Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.
... is of great importance for genome integrity and plays a crucial role in cancer initia- tion and ...the TERT gene as risk factors for many cancer types ...studies of TERT ...
13
Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies.
... none of the two polymorphisms was related to TR, PFS or OS in overall population, which is consistent with the findings of the previous meta-analysis by Ming Yin et ...ated with ...
11
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic review.
... which clinical factors could affect SPP (Table 3). The year of trial initiation was a significant factor (regression coefficient of ...associated with several clinical Figure ...NSCLC ...
8
Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
... Lung cancer leads cancer-related mortality worldwide. Non-small-cell lung cancer (NSCLC), the most prevalent subtype of this recalcitrant cancer, is ...
11
Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer.
... Department of Thoracic Medical Oncology, Peking University Cancer Hospital, which was established in June 1999 and have possessed around 1900 patients with tissues samples which had been ...
7
Analysis of Prognostic Factors in 541 Female Patients with Advanced Non-small Cell Lung Cancer
... predictors of outcome with geitinib in a phase III placebocontrolled study in advanced non-small-cell lung ...impact of induction chemotherapy ...
6
Einstein (São Paulo) vol.13 número2
... and clinical outcomes of non-small-cell lung cancer patients exposed to erlotinib in any line of ...study of non- small-cell ...
6
Rev. Hosp. Clin. vol.56 número2
... For patients with non-small cell lung cancer (NSCLC), the prospect of long-term survival is directly related to the surgical resectability of the primary ...
6
Inglês Jornal Brasileiro de Pneumologia complete v42n5 EN
... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ...objective ...
102
J. bras. pneumol. vol.42 número5
... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ...objective ...
9
The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
... Interstitial lung disease (ILD) is considered as a major safety concern for ...incidence of ILD among gefitinib-treated patients was ...rate of ILD was reported to be ...in patients ...
11
Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
... component of inflammation, is the first type of immune cell that responds to the site of infection and attack invaders ...in patients with non-hematologic neoplasms ...
14
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.
... member of the human epidermal growth factor receptor (HER) family, plays a critical role in regulating multiple cellular processes including proliferation, differentiation, cell migration and cell ...
22
MicroRNA expression and clinical outcome of small cell lung cancer.
... role of microRNAs in small-cell lung carcinoma (SCLC) is largely ...a cancer type with frequent dysfunction of ...expression of a panel of 7 microRNAs ...
8
Polymorphisms of homologous recombination genes and clinical outcomes of non-small cell lung cancer patients treated with definitive radiotherapy.
... associated with a reduced RP incidence but a decreased ...proportion of patients with mild/moderate RP (grade 1 and 2), which was not likely to have an impact on patients’ survival ...
9
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice
... differentiation of reticulocytes to mature ...filled with small membrane vesicles of uniform size (40-100 ...dimers of the Major Histocompatibility Complex class II (MHCII) bound to ...
13
An Overview: Treatment of Lung Cancer on Researcher Point of View
... ung cancer leads to death including both man & woman ...diagnosis of lung cancer in patient. The risk of most redundant outcome of this disease (death) can be ...
7
Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
... introduction of a targeted therapy for molecularly selected patient subgroups like patients with an EGFR activation mutation, impressive im- provements in the treatment of lung ...
10
Potential role of immunotherapy in advanced non-small-cell lung cancer
... treatment of advanced NSCLC. The large set of susceptible patients for this scenario emerges concurrently with the competitive research trials among the main pharmaceutical sponsors and ...
10
J. bras. pneumol. vol.36 número5 en v36n5a10
... quartiles of the quantitative ...start of treatment), we used the Friedman ...distribution of the patients among the weight groups at the different time points, we determined bilateral ...
7
